SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $52,266,000 | +11.2% | 267,087 | -3.5% | 0.04% | 0.0% |
Q2 2020 | $47,022,000 | +21.6% | 276,729 | -17.4% | 0.04% | +2.9% |
Q1 2020 | $38,667,000 | +13.8% | 335,128 | +12.7% | 0.04% | +59.1% |
Q4 2019 | $33,983,000 | +104.1% | 297,448 | +52.5% | 0.02% | +83.3% |
Q3 2019 | $16,651,000 | +80.0% | 195,024 | +45.8% | 0.01% | +140.0% |
Q2 2019 | $9,252,000 | +26.2% | 133,729 | +33.5% | 0.01% | +25.0% |
Q1 2019 | $7,334,000 | +66.0% | 100,188 | +28.5% | 0.00% | +33.3% |
Q4 2018 | $4,417,000 | -75.9% | 77,996 | -67.1% | 0.00% | -40.0% |
Q3 2018 | $18,302,000 | -67.2% | 237,349 | -71.8% | 0.01% | -68.8% |
Q2 2018 | $55,857,000 | +60.0% | 841,385 | +26.1% | 0.02% | -5.9% |
Q1 2018 | $34,912,000 | +94.3% | 667,102 | +98.5% | 0.02% | +41.7% |
Q4 2017 | $17,971,000 | -62.1% | 335,989 | -61.5% | 0.01% | -62.5% |
Q3 2017 | $47,430,000 | +14.3% | 871,816 | +8.7% | 0.03% | +6.7% |
Q2 2017 | $41,491,000 | -21.3% | 802,048 | -4.3% | 0.03% | -23.1% |
Q1 2017 | $52,705,000 | +17.0% | 838,508 | -1.8% | 0.04% | +8.3% |
Q4 2016 | $45,044,000 | -14.0% | 853,710 | -11.9% | 0.04% | -2.7% |
Q3 2016 | $52,348,000 | +33.5% | 969,314 | -0.1% | 0.04% | +32.1% |
Q2 2016 | $39,223,000 | +42.9% | 970,683 | +24.1% | 0.03% | +33.3% |
Q1 2016 | $27,456,000 | -10.4% | 782,468 | +14.6% | 0.02% | 0.0% |
Q4 2015 | $30,645,000 | -22.6% | 682,906 | -33.5% | 0.02% | -32.3% |
Q3 2015 | $39,571,000 | -3.7% | 1,026,324 | +20.9% | 0.03% | +19.2% |
Q2 2015 | $41,098,000 | +100.4% | 849,192 | +46.4% | 0.03% | +100.0% |
Q1 2015 | $20,508,000 | -7.4% | 580,221 | -15.8% | 0.01% | -7.1% |
Q4 2014 | $22,144,000 | -13.4% | 689,291 | +0.2% | 0.01% | -12.5% |
Q3 2014 | $25,568,000 | -26.2% | 687,764 | -24.1% | 0.02% | -33.3% |
Q2 2014 | $34,668,000 | -7.6% | 906,446 | +9.9% | 0.02% | -11.1% |
Q1 2014 | $37,525,000 | +33.1% | 824,872 | +16.7% | 0.03% | +35.0% |
Q4 2013 | $28,200,000 | +1.1% | 707,011 | +11.1% | 0.02% | -4.8% |
Q3 2013 | $27,881,000 | – | 636,159 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |